<DOC>
	<DOCNO>NCT00174447</DOCNO>
	<brief_summary>Open label extension study Ziprasidone , evaluation safety long term use ziprasidone</brief_summary>
	<brief_title>Extension Study Patients Successfully Treated Ziprasidone Study A1281031</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>Patients successfully complete study A1281031 ( CGI score 1 2 final visit ) ZIPNY98035 QTc &lt; = 500 msec . All patient fit inclusion criterion state .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>